Back to dashboard
MedicaidPrior AuthMedium impact

21-726 Medication Trend Updates and Formulary Changes - 4th Quarter 2021

Health Net·CA · Oncology, Neurology, Internal Medicine +1 more·Prior Authorization
Effective date
Not stated
We identified it
Jun 20, 2026
Days to comply

Summary

CalViva Health Medi-Cal updated their formulary for Q4 2021, adding three new injectable medications (Abecma, Aduhelm, and Nulibry) that require prior authorization under medical benefit. The policy also includes new buprenorphine prescribing guidelines for opioid use disorder treatment with expanded access for physicians.

Action Required

Action needed
Immediately: For CalViva Health Medi-Cal patients in Fresno, Kings, and Madera counties, billing team must verify prior authorization is obtained before administering Abecma (idecabtagene vicleucel), Aduhelm (aducanumab), or Nulibry (fosdenopterin) IV infusions. Update billing system to flag these medications as requiring PA verification. Providers should use the CalViva Health portal for real-time PA status checks.